Position in FLGT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,495,100
+$1,974,041 QoQ
Shares Held
1,289,000
+82.8% QoQ
Ownership
4.54%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FLGT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RTW INVESTMENTS, LP holds $715,677,085 across 6 Diagnostics & Research names. FLGT ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,250,000 | $249,987,500 | |
| 2 | RDNT |
RadNet, Inc.
|
4,285,000 | $239,488,650 | |
| 3 | GH |
Guardant Health, Inc.
|
1,481,033 | $136,803,018 | |
| 4 | CSTL |
Castle Biosciences Inc
|
2,758,335 | $67,717,124 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
This page
|
1,289,000 | $20,495,100 | |
| 6 | XGN |
Exagen Inc.
|
395,231 | $1,185,693 |
All Filings in FLGT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,495,100 | 1,289,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,521,059 | 705,027 | Shares | Sole | 2026-02-17 | |
| 2020-06-30 | $1,200,000 | 75,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $807,000 | 75,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||